Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens

Arthritis and Rheumatism

Volumn 41, Issue 7, 1998, Pages 1152-1160

  Utz, Paul J ^a   Anderson, Paul ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 0031863698     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L     Document Type: Review

References (91)

1. Vaishnaw A, McNally JD, Elkon KB. Apoptosis in the rheumatic diseases. Arthritis Rheum 1997;40:1917-27.
2. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:311-35.
3. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58.
4. Reeves W, Satoh M, Wang J, Chou C, Ajmani A. Systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20:1-28.
5. Rumore P, Steinman C. Endogenous circulating DNA in systemic lupus erythematosus: occurrence as multimenc complexes bound to histone. J Clin Invest 1990;86:69-74.
6. Kanai Y, Kyuwa S, Miura K, Kurosawa Y. Induction and natural occurrence of serum nucleosomal DNA in autoimmune MRL/lpr/ lpr mice: its relation to apoptosis in the thymus. Immunol Lett 1995;46:207-14.
7. Bell D, Morrison B. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol 1991;60:13-26.
8. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
9. Itescu S. Rheumatic aspects of acquired immunodeficiency syndrome. Curr Opin Rheumatol 1996;8:346-53.
10. Sontheimer R. Photobiology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 1996;63:583-94.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured keratinocytes. J Clin Invest 1984;74: 1317-30.
13. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992;90:1067-76.
14. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on cultured keratinocytes. J Exp Med 1994;179: 1317-30.
15. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995;181: 1557-61.
16. Korb L, Ahearn J. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. J Immunol 1997;158: 4525-8.
17. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996;93:1624-9.
18. Gilligan H, Bredy B, Brady H, Hebert M-J, Slayter H, Xu Y, et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996;184:2231-41.
19. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997;6:175-80.
20. Alnemri E, Livingston D, Nicholson D, Salveson G, Thornberry N, Wong W, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
21. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70 kDa protein component of the U1 small nuclear riboprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994;269:30757-60.
22. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-34.
23. Anderson P. Kinase cascades regulating entry into apoptosis. Microbiol Mol Biol Rev 1997;61:33-46.
24. Ghayur T, Hugunin M, Talanian R, Ratnofsky S, Quinlan C, Emoto Y, et al. Proteolytic activation of protein kinase C delta by an ICE/CED2-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399-404.
25. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 1995;14:6148-56.
26. Rudel T, Bokoch G. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997;276:1571-4.
27. Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem 1997;272:20317-20.
28. Cardone M, Salvesen G, Widmann C, Johnson G, Frisch S. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997;90:315-23.
29. Utz PJ, Hottelet M, Schur P, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997;185:843-54.
30. Utz PJ, Hottelet M, van Venrooij W, Anderson P. Association of phosphorylated serine/arginine (SR) proteins and the U1-small nuclear ribonuclear protein (snRNP) autoantigen complex accompanies apoptotic cell death. J Exp Med 1998;187:547-60.
31. Stetler D, Jacob S. Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus patients. J Biol Chem 1984;259:13629-32.
32. Abdel-Motal U, Berg L, Rosen A, Bengtsson M, Thorpe C, Kihlberg J, et al. Immunization with glycosylated K-b-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol 1996;26:544-51.
33. Harding C, Kihlberg J, Elofsson M, Magnusson G, Unanue E. Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol 1993;151:2419-25.
34. Casciola-Rosen L, Nicholson D, Chong T, Rowan K, Thornberry N, Miller D, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1997;183:1957-64.
35. Hochstrasser M. Protein degradation or regulation: Ub the judge. Cell 1996;84:813-5.
36. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997;185:71-9.
37. Enestrom S, Hultman P. Does amalgam affect the immune system? A controversial issue [letter]. Int Arch Allergy Immunol 1995;106:180.
38. Takeuchi K, Turley SJ, Tan EM, Pollard KM. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J Immunol 1995;154:961-71.
39. Pollard K, Lee D, Casiano C, Bluthner M, Johnston M, Tan E. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 1997;158:3521-8.
40. Piacentini M, Colizzi V. Does "tissue" transglutaminase prevent "cryptic self" antigen spreading from apoptotic cells? Immunol Today. In press.
41. Elouaai F, Lule J, Benoist H, Appolinaire-Pilipenko S, Atanassov C, Muller S, et al. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB X NZW and MRL-lpr/lpr mice: anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol Dial Transplant 1995;9:362-6.
42. Marushige Y, Marushige K. Disappearance of ubiquitinated histone H2A during chromatin condensation in TGFβ1-induced apoptosis. Anticancer Res 1995;15:267-72.
43. Schellekens G, de Jong B, van den Hoogen F, van de Putte L, van Venrooij W. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
44. Price B, Rauch J, Shia M, Walsh M, Lieberthal W, Gilligan H, et al. Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 1996;157:2201-8.
45. Shan H, Shlomchik M, Marshak-Rothstein A, Pisetsky D, Litwin S, Weigert M. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J Immunol 1994;153:5104-20.
46. Craft J, Mimori T, Olsen T, Hardin J. The U2 small nuclear ribonucleoprotein particle as an autoantigen. J Clin Invest 1988; 81:1716-24.
47. Craft J, Fatenejad S. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997;40:1374-82.
48. Habets W, Hoet M, de Jong B, van der Kemp A, van Venrooij W. Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J Immunol 1989;143:2560-6.
49. Kakkanaiah V, Sobel E, MacDonald G, Cheek R, Cohen P, Eisenberg R. B cell genotype determines the fine specificity of autoantibody in lpr mice. J Immunol 1997;159:1027-35.
50. Satoh M, Richards H, Hamilton K, Reeves W. Human antiribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Smith core complex. J Immunol 1997;158:5017-26.
51. Cohen P, Eisenberg R. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-56.
52. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
53. Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-56
54. Halpern M, Fisher C, Cohen P, Eisenberg R. Influence of the IgH chain locus on autoantibody production in autoimmune mice. J Immunol 1992;149:3735-9.
55. Koh D, Ho A, Rahemutulla A, Fung-Leung W, Griesser H, Mak T. Murine lupus MRL/lpr mice lacking CD4 or CD8 T cells. J Immunol 1995;25:2558-61.
56. Jevnikar A, Grusby M, Glimcher L. Prevention of nephritis in major histocompatibility complex class H-deficient MRL-lpr mice. J Exp Med 1994;179:1137-43.
57. Peng S, Madaio M, Hughes D, Crispe I, Owen M, Wen L, et al. Murine lupus in the absence of alpha-beta T cells. J Immunol 1996;156:4041-9.
58. Striebich C, Miceli R, Schulze D, Kelsoe G, Cerny J. Antibody-binding repertoire and Ig H chain gene usage among B cell hybridomas from normal and autoimmune mice. J Immunol 1990;144:1857-65.
59. Souroujon M, White-Scharff M, Andre-Schwartz J, Gefter M, Schwartz R. Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J Immunol 1988;140:4173-9.
60. Rousseau P, Mallett C, Smith-Gill S. A substantial proportion of the adult Balb/c available B cell repertoire consists of multireactive B cells. Mol Immunol 1989;26:993-1006.
61. Casali P, Notkins A. Probing the B cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 1989;7:513-35.
62. Cyster J. Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol Rev 1997;156:87-101.
63. Conger J, Pike B, Nossal G. Clonal analysis of the anti-DNA repertoire of murine B lymphocytes. Proc Natl Acad Sci U S A 1987;84:2931-5.
64. Nossal G. Negative selection of lymphocytes. Cell 1994;76:229-39.
65. Rolink A, Radaszkiewicz T, Meltcher F. The autoantigen-binding B cell repertoires of normal and chronically graft-versus-host diseased mice. J Exp Med 1987;165:1675-87.
66. Woppmann A, Will C, Kornstadt U, Zuo P, Manley J, Luhrmann R. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. Nucleic Acids Res 1993;21:2815-22.
67. Chen Z, Parent L, Maniatis T. Site-specific phosphorylation ot IκB alpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-62.
68. Lorenz A-M, Grünke M, Hieronymus T, Herrmann M, Künnel A, Manger B, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40:306-17.
69. Richardson BC, Yung RL, Johnson KJ, Rowse PE, Lalwani ND. Monocyte apoptosis in patients with active lupus [letter]. Arthritis Rheum 1996;39:1432-4.
70. Vaux D, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994;76:777-9.
71. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1-15.
72. Shen Y, Shenk T. Viruses and apoptosis. Curr Opin Genet Dev 1995;5:105-11.
73. Butcher G. Malaria and macrophage function in Africans: a possible link with autoimmune disease? Med Hypotheses 1996;47: 97-100.
74. Furukawa F, Kashihara-Sawami, Lyons M, Norris D. Binding of autoantibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light: implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990;94:77-85.
75. Kalden J. Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 1997;6:326-7.
76. Mevorach D, Zhou JL, Elkon K. Immunization of mice with apoptotic cells induces low levels of autoantibodies [abstract]. Arthritis Rheum 1996;39 Suppl 9:S143.
77. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/Apo-1)-mediated T cell apoptosis. J Exp Med 1996;184:765-70.
78. Meliconi R, Bestagno M, Sturani C, Negri C, Galavotti V, Sala C, et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol 1989;76:184-9.
79. Lazebnik Y, Kaufmann S, Desnoyers S, Poirier G, Earnshaw W. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-7.
80. Stanek D, Vencovský J, Kafková J, Raska I. Heterogeneous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Arthritis Rheum 1997;40:2172-7.
81. Lazebnik Y, Takahashi A, Moir R, Goldman R, Poirier G, Kaufmann S, et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci U S A 1995;92:9042-6.
82. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997;276:604-7.
83. Kayalar C, Ord T, Testa M, Zhong L-T. Bredesen D. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci U S A 1996;93:2234-8.
84. Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Antiact in antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995;48:129-32.
85. Spain TA, Sun R, Gradzka M, Lin S-F, Craft J, Miller G. The transcriptional activator Sp1, a novel autoantigen. Arthritis Rheum 1997;40:1085-95.
86. Piedrafita F, Pfahl M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 1997;17:6348-58.
87. Grubauer G, Romani N, Kofler H, Stanzl U, Fritsch P, Hintner H. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies. J Invest Dermatol 1986;87:466-71.
88. Caulin C, Salvesen G, Oshima R. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-94.
89. Adyel FZ, Hentati B, Boulila A, Hachicha J, Ternynck T, Avrameas S, et al. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic erythematosus patients. J Clin Lab Anal 1996;10: 451-7.
90. Haralambous S, Blackwell C, Mappouras D, Weir D, Kemmett D, Lymberi P. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with and without insulin-dependent diabetes mellitus. Autoimmumty 1995; 20:267-75.
91. Nakajima T, Monta K, Ohi N, Arai T, Nozaki N, Kikuchi A, et al. Degradation of topoisomerase II alpha during adenovirus EIA-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J Biol Chem 1996;271:24842-9.